PHP
GRTS

Parkman Healthcare Partners’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

Parkman Healthcare Partners’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-151,921
Closed -$422K – 106
2023
Q1 		$422K Buy
+151,921
New +$434K 0.09% 80

Other funds holding GRTS

Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parkman Healthcare Partners's GRTS Position: Q2 2023 in Review

Parkman Healthcare Partners sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q2 2023, closing a stake of 151,921 shares — an estimated $422K sold.

Parkman Healthcare Partners first reported a position in GRTS in Q1 2023 and held it in 1 quarter. The position peaked at $422K in Q1 2023. 88 funds tracked by Wall St. Rank hold GRTS as of Q2 2023.

  • Parkman Healthcare Partners reported no remaining Gritstone bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Parkman Healthcare Partners sold 151,921 Gritstone bio, Inc. Common Stock shares in Q2 2023, an estimated $422K.
  • Parkman Healthcare Partners first reported a position in Gritstone bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
  • Parkman Healthcare Partners's Gritstone bio, Inc. Common Stock position peaked at $422K in Q1 2023.
  • 88 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q2 2023.

Based on Parkman Healthcare Partners's 13F filing for Q2 2023, filed 11 Aug 2023.